Breakthrough research identifies fibrin as key factor in preterm brain bleeds

FHS
July 24, 2024
11:52 pm

Mark Petersen, MD, has seen firsthand the devastating effects of brain bleeds in premature babies. It’s an exceedingly common condition that affects up to 20 percent of infants born before 28 weeks of gestation, bringing an increased risk for developmental delays and autism.

Signal: British biopharma applies for BLA for T-cell cancer therapy – Pharmaceutical Technology

Share this article Acute lymphoblastic leukaemia seen in human blood. Illustration: Science Photo Library/Getty Images. British biopharmaceuticals company Autolus Therapeutics has submitted a Biologics License

November 27, 2023

Opinion | Project 2025: Assessing the Impact on the Healthcare Workforce

Oyeyemi, Portela, and Salsberg are health workforce researchers. Prepared by a think tank with ties to former President Donald Trump, Project 2025 has been in

September 10, 2024

Steroid Tapering Called Safe in Older RA Patients

Most rheumatoid arthritis (RA) patients 65 and older who had 5 mg/day of prednisolone added to standard care were successfully weaned from the steroid without

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.